Sophia Genetics

Yahoo Finance • 11 days ago

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

BOSTON, Sept. 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & C... Full story

Yahoo Finance • 2 months ago

SOPHiA GENETICS reaffirms $72M–$76M 2025 revenue guidance as AstraZeneca deal drives BioPharma outlook

Earnings Call Insights: SOPHiA GENETICS SA (SOPH) Q2 2025 MANAGEMENT VIEW * CEO Jurgi Camblong reported, "revenue growth continued to reaccelerate and cash burn decreased notably," highlighting that total revenue grew 16% year-over-yea... Full story

Yahoo Finance • 2 months ago

Sophia Genetics files $200M mixed securities shelf

* Sophia Genetics (NASDAQ:SOPH [https://seekingalpha.com/symbol/SOPH]) filed $200M mixed securities shelf. * Filing [https://seekingalpha.com/filing/10270651] MORE ON SOPHIA GENETICS * Seeking Alpha’s Quant Rating on SOPHiA Genetic... Full story

Yahoo Finance • 2 months ago

SOPHiA Genetics GAAP EPS of -$0.33, revenue of $18.3M

* SOPHiA Genetics press release [https://seekingalpha.com/pr/20188592-sophia-genetics-reports-second-quarter-2025-results] (NASDAQ:SOPH [https://seekingalpha.com/symbol/SOPH]): Q2 GAAP EPS of -$0.33. * Revenue of $18.3M. *   MORE ON... Full story

Yahoo Finance • 2 months ago

SOPHiA GENETICS SA (NASDAQ:SOPH) Beats Q2 2025 Earnings Estimates, Shares Jump in Pre-Market Trading

SOPHIA GENETICS SA (NASDAQ:SOPH [https://www.chartmill.com/stock/quote/SOPH/profile]) SURPASSES ANALYST ESTIMATES IN Q2 2025, SHARES RISE IN PRE-MARKET TRADING SOPHiA GENETICS SA reported its second-quarter 2025 earnings, delivering both... Full story

Yahoo Finance • 2 months ago

Sophia Genetics earnings missed by $0.11, revenue topped estimates

Investing.com - Sophia Genetics (NASDAQ: SOPH) reported second quarter EPS of $-0.330, $0.11 worse than the analyst estimate of $-0.220. Revenue for the quarter came in at $18.3M versus the consensus estimate of $17.49M. Guidance Sophi... Full story

Yahoo Finance • 2 months ago

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with Astr... Full story

Yahoo Finance • 2 years ago

SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain

SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and ROLLE, Switzerland and MADRID, Feb. 7, 2024 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native soft... Full story

Yahoo Finance • 2 years ago

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023

BOSTON and ROLLE, Switzerland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for the third quarter ended Septem... Full story

Yahoo Finance • 2 years ago

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023

BOSTON and GENEVA, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the thir... Full story

Yahoo Finance • 2 years ago

SOPHiA GENETICS Reports Financial Results for the First Quarter of Fiscal 2023  

BOSTON and LAUSANNE, Switzerland, May 09, 2023 (GLOBE NEWSWIRE) --  SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the first quarter ended March 31, 2023.... Full story

Yahoo Finance • 2 years ago

SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2023 on May 9, 2023

BOSTON and GENEVA, Switzerland, April 25, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the first quarter of fi... Full story

Yahoo Finance • 3 years ago

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022

BOSTON and LAUSANNE, Switzerland, Nov. 08, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the third quarter ended September 30, 20... Full story

Yahoo Finance • 3 years ago

SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference

BOSTON and LAUSANNE, Switzerland, Sept. 02, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today Chief Executive Officer, Dr. Jurgi Camblong and Chief Financ... Full story

Yahoo Finance • 3 years ago

SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022

BOSTON and LAUSANNE, Switzerland, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the second quarter ended June 30, 2022.... Full story

Yahoo Finance • 3 years ago

SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City

BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its first-ever Investor Day on Tuesday, Septembe... Full story

Yahoo Finance • 3 years ago

SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference

BOSTON and LAUSANNE, Switzerland, July 29, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Financial Officer, Ross Muken, will attend and be a panelist at the Canaccord... Full story

Yahoo Finance • 3 years ago

SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022

BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal 2022 before U... Full story

Yahoo Finance • 3 years ago

SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference

BOSTON and LAUSANNE, Switzerland, April 27, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced CFO, Ross Muken will attend the upcoming J.P. Morgan 50th Annual Global Technology,... Full story

Yahoo Finance • 3 years ago

SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022

BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal 2022 before U... Full story